Caplin Point Laboratories Ltd
Hari Kishan Komma is an experienced professional in the field of Regulatory Affairs with over 25 years in the pharmaceutical industry. Currently serving as the Head of Regulatory Affairs at Caplin Point Laboratories Ltd since September 2013, Hari oversees global registrations for injectable and ophthalmic formulations in highly regulated markets and in emerging markets. Previous roles include DGM of Regulatory Affairs at Gland Pharma Limited, where responsibility involved leading teams for efficient regulatory submissions, and Sr. Manager roles at both Promed Exports Pvt Ltd and Gland Pharma Limited, focusing on market authorization applications and ANDA submissions. Additionally, early career experience at Dai-Ichi Karkaria Ltd encompassed production of sterile injectables and tablets.
This person is not in any teams
This person is not in any offices
Caplin Point Laboratories Ltd
1 followers
Caplin Point Laboratories Limited is a pharmaceutical company. The Company's product segments include Antibiotics, Non-steroidal anti-inflammatory drugs (NSAIDS), Ophthalmics, Pain Management and Anti-ulcers. The Company offers a range of products, including Tablets, Liquid Orals, Capsule, Softgel Capsules, Suppositories and Ovules, Powder for Injection, Dry syrup, Topicals, Liquid Injections, Inhalers, intravenous (IV) Infusion, Lyophilized Products, Branded Products, Dermo Cosmetics and Other Products. It also manufactures a range of ointments, creams, gels and lotions. The Company has presence in Latin American nations of Guatemala, Honduras, Nicaragua, El Salvador, Ecuador, Honduras, Venezuela and Dominican Republic. The Company's manufacturing facilities are located in Suthukeny village, Puducherry; Gummidipoondi Taluk, Tamil Nadu, and Baddi, Himachal Pradesh. Its research and development units are located in Gummidipoondi Taluk, Tamil Nadu.